The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Gliadin Deamidated Peptide Antibody IgA
The Gliadin (Deamidated Peptide) Antibody (IgA) test contains 1 test with 1 biomarker.
Brief Description: The Gliadin IgA Antibody test, also known as the IgA anti-gliadin antibody test, measures the levels of specific antibodies called immunoglobulin A (IgA) directed against gliadin in the blood. Gliadin is a protein found in gluten, which is present in wheat, barley, and rye. This test is used to assist in the diagnosis of certain gluten-related disorders, specifically celiac disease.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: No preparation required
A Gliadin IgA Antibody test may be ordered when there is a suspicion of celiac disease or non-celiac gluten sensitivity. It is not a standalone test for diagnosing celiac disease, but it can be used as part of a panel of tests that includes other celiac-related antibodies and intestinal biopsies.
The test may be ordered if an individual has symptoms such as chronic diarrhea, abdominal pain, bloating, unexplained weight loss, and malabsorption. It may also be ordered if someone has a family history of celiac disease or if they have other autoimmune conditions that are commonly associated with celiac disease.
The Gliadin IgA Antibody test checks for the presence of IgA antibodies directed against gliadin, a protein found in gluten. In individuals with celiac disease or gluten sensitivity, the immune system reacts to gliadin, leading to the production of these specific antibodies.
When a Gliadin IgA Antibody test is ordered, it's often part of a broader evaluation for celiac disease and related gastrointestinal disorders. Here are some tests commonly ordered alongside it:
Tissue Transglutaminase Antibody (tTG-IgA):
Serum Iron, Ferritin, and Folate Levels:
These tests, when ordered alongside a Gliadin (Deamidated Peptide) IgA Antibody test, provide a comprehensive assessment of the potential presence of celiac disease and its effects on the body. They are crucial for diagnosing celiac disease, understanding its impact on the patient's health, and guiding dietary and treatment strategies. The specific combination of tests will depend on the individual’s symptoms, medical history, and risk factors.
A Gliadin IgA Antibody test is primarily used to aid in the diagnosis of celiac disease and non-celiac gluten sensitivity. Celiac disease is an autoimmune disorder triggered by the ingestion of gluten, leading to damage to the small intestine and malabsorption of nutrients.
Healthcare providers use the results of the Gliadin IgA Antibody test, along with other celiac-related antibody tests and clinical evaluation, to determine if a patient has celiac disease or gluten sensitivity. If the results indicate positive celiac-related antibodies and the patient has compatible symptoms, an intestinal biopsy may be performed to confirm the diagnosis.
A definitive diagnosis of celiac disease can prompt the implementation of a strict gluten-free diet, which is the mainstay of management for celiac patients. The test results also guide healthcare providers in providing appropriate counseling and monitoring for individuals with gluten-related disorders.
What does the Gliadin (Deamidated Peptide) IgA Antibody test measure?
The Gliadin (Deamidated Peptide) IgA Antibody test measures the level of IgA antibodies against deamidated gliadin peptides (DGP) in the blood. These antibodies are often present in individuals with celiac disease, an autoimmune disorder that results in damage to the small intestine when foods containing gluten are consumed.
What do the results of the Gliadin (Deamidated Peptide) IgA Antibody test mean?
The results of the test are typically reported as positive or negative. A positive result suggests that the individual might have celiac disease. However, further diagnostic evaluation, often including a biopsy of the small intestine, is required to confirm the diagnosis.
Why is the Gliadin (Deamidated Peptide) IgA Antibody test important?
This test is crucial in the initial screening for celiac disease, particularly in individuals with symptoms suggestive of this condition or in those with a family history of celiac disease.
Can the Gliadin (Deamidated Peptide) IgA Antibody test be used in the management of certain diseases?
Yes, this test can be used in the management of celiac disease. Once a diagnosis of celiac disease is established, this test can be used to monitor the individual's response to a gluten-free diet.
What does a positive Gliadin (Deamidated Peptide) IgA Antibody test result indicate?
A positive test result suggests the presence of IgA antibodies against DGP, which is commonly seen in celiac disease. This may suggest that the individual has celiac disease, but other confirmatory tests are usually required.
What does a negative Gliadin (Deamidated Peptide) IgA Antibody test result indicate?
A negative test result suggests the absence of IgA antibodies against DGP in the blood. This typically indicates that the individual does not have celiac disease. However, a small percentage of people with celiac disease may not produce these antibodies and thus may test negative.
How can Gliadin (Deamidated Peptide) IgA Antibody test results impact treatment decisions?
A positive result can lead to further diagnostic testing for celiac disease. If the diagnosis is confirmed, the main treatment is a lifelong gluten-free diet.
Can the Gliadin (Deamidated Peptide) IgA Antibody test results guide the choice of medication?
Celiac disease is primarily managed with a gluten-free diet rather than medication. However, the results of this test can help monitor the individual's adherence to the diet and its effectiveness in reducing antibody levels.
Can the presence of other diseases influence Gliadin (Deamidated Peptide) IgA Antibody test results?
Yes, other autoimmune diseases or inflammatory bowel diseases can occasionally lead to a positive result on this test, even without the presence of celiac disease.
Can lifestyle changes affect the Gliadin (Deamidated Peptide) IgA Antibody test results?
Yes, adopting a gluten-free diet can lead to a decrease in the level of these antibodies, potentially resulting in a negative test result.
What are the limitations of the Gliadin (Deamidated Peptide) IgA Antibody test?
The main limitation of this test is that a positive result is not definitive for celiac disease. Other conditions can sometimes lead to a positive result. Also, some individuals with celiac disease may not produce these antibodies and thus may test negative.
Can the results of the Gliadin (Deamidated Peptide) IgA Antibody test change over time?
Yes, the levels of these antibodies can decrease with adherence to a gluten-free diet.
How does the Gliadin (Deamidated Peptide) IgA Antibody test fit into the current understanding of celiac disease?
The Gliadin (Deamidated Peptide) IgA Antibody test is a crucial part of the initial screening process for celiac disease and can help guide further diagnostic evaluation.
Are there more recent diagnostic methods that may supersede the Gliadin (Deamidated Peptide) IgA Antibody test?
While this test continues to play an important role, the tissue transglutaminase (tTG) IgA test is now more commonly used as the first-line screening test for celiac disease.
How might future research impact the use of the Gliadin (Deamidated Peptide) IgA Antibody test?
Future research may lead to the development of more accurate tests for celiac disease or increase our understanding of the conditions that can lead to a positive test result. This could potentially impact the use of the Gliadin (Deamidated Peptide) IgA Antibody test.
Can the Gliadin (Deamidated Peptide) IgA Antibody test help identify non-celiac gluten sensitivity?
This test is primarily used to detect celiac disease, and its role in identifying non-celiac gluten sensitivity is not established.
Can the Gliadin (Deamidated Peptide) IgA Antibody test be used in individuals already diagnosed with celiac disease?
Yes, this test can be used to monitor adherence to a gluten-free diet in individuals diagnosed with celiac disease.
What factors can interfere with the results of the Gliadin (Deamidated Peptide) IgA Antibody test?
Certain conditions, such as IgA deficiency, can interfere with the results of this test. Individuals with this deficiency may not produce the antibodies this test is designed to detect.
Is it possible to have a false-positive or false-negative Gliadin (Deamidated Peptide) IgA Antibody test result?
Yes, it is possible to have a false-positive or false-negative result. Some individuals with celiac disease may not produce the antibodies detected by this test, leading to a false-negative result. Conversely, other autoimmune or inflammatory conditions can lead to a false-positive result.
Can the Gliadin (Deamidated Peptide) IgA Antibody test distinguish between active and inactive celiac disease?
Yes, this test can help distinguish between active and inactive celiac disease. Active disease is typically associated with higher levels of these antibodies, which should decrease once the individual adopts a gluten-free diet.
Can the Gliadin (Deamidated Peptide) IgA Antibody test predict the development of celiac disease in at-risk individuals?
While the test can indicate an increased risk of celiac disease in individuals with a positive result, it cannot predict with certainty whether an individual will develop the disease.
Can the Gliadin (Deamidated Peptide) IgA Antibody test detect the presence of gluten in the diet?
The test detects the body's immune response to gluten, not the presence of gluten itself. However, a positive result or an increase in antibody levels in someone with diagnosed celiac disease can suggest ongoing gluten consumption.
What is the role of the Gliadin (Deamidated Peptide) IgA Antibody test in non-celiac autoimmune disorders?
In some cases, this test may be used in the evaluation of individuals with other autoimmune disorders, given the higher prevalence of celiac disease in this group compared to the general population.
How often should the Gliadin (Deamidated Peptide) IgA Antibody test be performed in individuals with celiac disease?
After an initial diagnosis of celiac disease, the test may be repeated to monitor the individual's response to a gluten-free diet. The frequency of testing should be determined by the individual's healthcare provider.
How does the Gliadin (Deamidated Peptide) IgA Antibody test compare with other tests for celiac disease?
The Gliadin (Deamidated Peptide) IgA Antibody test is a valuable tool in the diagnosis of celiac disease. However, the tissue transglutaminase (tTG) IgA test is often used as the first-line screening test due to its high sensitivity and specificity for celiac disease.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.